185 related articles for article (PubMed ID: 943332)
1. Pregnancy following 2-bromo-alpha-ergocryptine (CB-154)-induced ovulation in an acromegalic patient with galactorrhea and amenorrhea.
Aono T; Shioji T; Kohno M; Ueda G; Kurachi K
Fertil Steril; 1976 Mar; 27(3):341-4. PubMed ID: 943332
[TBL] [Abstract][Full Text] [Related]
2. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
Seki K; Seki M; Okumura T
Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
[TBL] [Abstract][Full Text] [Related]
3. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
March CM; Kletzky OA; Davajan V
Fertil Steril; 1977 May; 28(5):521-5. PubMed ID: 404198
[TBL] [Abstract][Full Text] [Related]
4. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
Dickey RP; Stone SC
Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
[TBL] [Abstract][Full Text] [Related]
5. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
Lloyd SJ; Josimovich JB; Archer DF
Am J Obstet Gynecol; 1975 May; 122(1):85-9. PubMed ID: 1168997
[TBL] [Abstract][Full Text] [Related]
6. Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.
Künzig HJ; Geiger W; Schulz KD; Lose KH
Arch Gynakol; 1975; 218(2):85-94. PubMed ID: 1174026
[TBL] [Abstract][Full Text] [Related]
7. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
Mroueh AM; Siler-Khodr TM
Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
[TBL] [Abstract][Full Text] [Related]
8. Predicted ovulatory response to 2-brom-alpha-ergocryptine (CB-154) in amenorrhea-galactorrhea syndromes.
Shewchuk AB; Corenblum B; Pairaudeau N; Ezrin C; Adamson GD
Am J Obstet Gynecol; 1980 Mar; 136(5):652-8. PubMed ID: 7188835
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.
Tyson JE; Khojandi M; Huth J; Smith B; Thomas P
Am J Obstet Gynecol; 1975 Feb; 121(3):375-9. PubMed ID: 1115151
[TBL] [Abstract][Full Text] [Related]
10. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
[TBL] [Abstract][Full Text] [Related]
11. [Several cases of amenorrhea and galactorrhea].
Moggi G; Giorgi G; Brunori di Luca I; Mazzotta A; Berti P; Archidiacono G; Giampietro O; Dalle Luche A
Minerva Ginecol; 1977 Nov; 29(11):833-5. PubMed ID: 565021
[No Abstract] [Full Text] [Related]
12. Bromocriptine-induced pregnancy in an acromegalic patient.
Luboshitzky R; Dickstein G; Barzilai D
JAMA; 1980 Aug; 244(6):584-6. PubMed ID: 7392156
[TBL] [Abstract][Full Text] [Related]
13. The significance of galactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea.
Davajan V; Kletzky O; March CM; Roy S; Mishell DR
Am J Obstet Gynecol; 1978 Apr; 130(8):894-904. PubMed ID: 565142
[TBL] [Abstract][Full Text] [Related]
14. Neurogenic galactorrhea-amenorrhea.
Boyd AE; Spare S; Bower B; Reichlin S
J Clin Endocrinol Metab; 1978 Dec; 47(6):1374-7. PubMed ID: 263659
[TBL] [Abstract][Full Text] [Related]
15. [Hyper- and normoprolactinaemia with amenorrhea and galactorrhea-amenorrhea-syndrom (author's transl)].
Schmolck A; Mettler L
Med Klin; 1979 Sep; 74(36):1273-8. PubMed ID: 582843
[TBL] [Abstract][Full Text] [Related]
16. [Hyperprolactinemic amenorrhea. Clinical relevance, endocrine features, therapy (author's transl)].
Rjosk HK; Werder K; Fahlbusch R
Geburtshilfe Frauenheilkd; 1976 Jul; 36(7):575-87. PubMed ID: 986336
[TBL] [Abstract][Full Text] [Related]
17. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
[TBL] [Abstract][Full Text] [Related]
18. Effects of CB-154 (2-Br-alpha-ergocryptine) on prolactin and growth hormone release in an acromegalic patient with galactorrhea.
Ueda G; Sato Y; Yamasaki M; Shioji T; Aono T
Endocrinol Jpn; 1975 Jun; 22(3):265-8. PubMed ID: 1242128
[TBL] [Abstract][Full Text] [Related]
19. Restoration of ovarian function by low nocturnal single daily doses of bromocriptine in patients with the galactorrhea-amenorrhea syndrome.
de Bernal M; de Villamizar M
Fertil Steril; 1982 Mar; 37(3):392-6. PubMed ID: 6800849
[TBL] [Abstract][Full Text] [Related]
20. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
Farrari C; Telloli P; Rampini P; Caldara R
Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
